TARDBP and myopathy: Serial studies in patients with chronic viral infections and signs of myopathy and/or sarcopenia would probably shed light on this progression, also regarding the progression to immunosenescence, mitochondrial dysfunction and proteinopathy, and the role of TDP-43 in this setting.